Ashley Braxton 
FDA’s reviewers found no new safety concerns after a second dose of J&J against COVID-19, but they cautioned about the small number of patients studied and short follow-up period.
FDA’s reviewers found no new safety concerns after a second dose of J&J against COVID-19, but they cautioned about the small number of patients studied and short follow-up period.
